KANSAI ELECTRIC POWER HOSPITAL
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1953-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
22
Active:0
Completed:18
Trial Phases
2 Phases
Phase 4:6
Not Applicable:16
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (22 trials with phase data)• Click on a phase to view related trials
Not Applicable
16 (72.7%)Phase 4
6 (27.3%)The Clinical Study to Assess the Effect of the Amount of Carbohydrate Intake and Meals Differing in Glycemic Index (GI) in Patients Treated With a Sodium-dependent Glucose Cotransporter 2 (SGLT2) Inhibitor
Not Applicable
Completed
- Conditions
- Diabetes Melltius, Type 2
- Interventions
- Other: Meal containing different carbohydrate ratio and GI value
- First Posted Date
- 2015-07-16
- Last Posted Date
- 2018-06-11
- Lead Sponsor
- Kansai Electric Power Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT02500186
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2019-07-01
- Lead Sponsor
- Kansai Electric Power Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT02312063
- Locations
- 🇯🇵
Saiseikai Noe Hospital Osaka, Osaka, Japan
🇯🇵Kansai Electric Power Hospital, Osaka, Japan
News
No news found